Β-Lysine
group of stereoisomers
β-Lysine (3,6-diaminohexanoic acid) is an amino acid produced by platelets during coagulation and is directly antibacterial by causing lysis of many Gram positive bacteria by acting as a cationic detergent. Beta Lysine contains a side chain with an amino group and is the beta form of the amino acid Lysine. Beta-Lysine can hydrogen bond at its carboxylic acid residue. Lysine is an amino acid that acts as a site for ubiquitination enzymes to bind to and branch from. Lysine is a positively charged amino acid due to its amino side chain (that contains an amine). This allows Beta-Lysine to directly interact with the negatively charged phosphate groups within nucleotides.
Beta-lysine is a non-specific immune defense factor that can be found in the blood of many animals, including birds this contributes to the innate immune system. Beta-Lysine in turn, can be a form of measure, of overall immune activity. Beta-Lysine activity is also responsive to many immunomodulators, such as preparations containing bacterial lipopolysaccharides, which increase the musical immune response which then leads to an increase in Beta-Lysine activity, further solidifying Beta-Lysine as an indicator and form of measure for innate immune response.
Begin with the source’s own compact description: “Β-Lysine” is group of stereoisomers. The dossier treats that line as a proposition to test through Β-Lysine, group and stereoisomers, not as a finished interpretation.
Why this record matters
The phrase “group of stereoisomers” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 14, 2026. The linked authority identifier is Q2930104. None of the 0 selected statements returned an explicit reference.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Β-Lysine”, its source revision and the description used here.
- Expand the search: follow Β-Lysine primary sources, Β-Lysine archive and Β-Lysine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Β-Lysine”?
- What terminology or title could unlock a more precise catalogue search?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Β-Lysine” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.